spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  ischemic cardiomyopathy 

 HSMN NewsFeed - 16 Sep 2019
BioVentrix Announces the Appointment of Pedro Marques as VP of Sales in Europe
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 6 Aug 2019
BioVentrix Announces Key Additions to Leadership Team
Devices Cardiology Personnel
 HSMN NewsFeed - 4 Oct 2017
BioVentrix Announces First Patient Enrolled in the U.S. arm of IDE Study of the Revivent TC(TM) TransCatheter Ventricular Enhancement Treatment
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Sep 2017
BioVentrix announces the 1st Revivent TC(TM) TransCatheter Ventricular Enhancement procedure for Ischemic Cardiomyopathy treatment at the University Heart Center Zurich in Switzerland
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Aug 2017
BioVentrix Announces First Patient Enrolled in IDE Study of the Revivent TC(TM) TransCatheter Ventricular Enhancement Treatment for Ischemic Cardiomyopathy
Devices Cardiology
 HSMN NewsFeed - 13 Mar 2017
BioVentrix announces the 1st Revivent TC(TM) TransCatheter commercial procedure to treat Ischemic Cardiomyopathy in China
Devices Cardiology
 HSMN NewsFeed - 6 Feb 2017
BioVentrix Announces NUB Reimbursement Status 1 for Revivent TC(TM) TransCatheter Ventricular Enhancement System in Germany
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 19 Dec 2016
BioVentrix Announces the 1st Revivent TC(TM) TransCatheter Ventricular Enhancement Procedure in Germany After Receiving CE-Mark Certification
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Oct 2016
Steven Healy appointed as Chairman of the Board of Directors of BioVentrix, Inc.
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 31 May 2016
BioVentrix receives FDA IDE Approval for its Pivotal Clinical Trial, ALIVE
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 28 Feb 2012
Bioheart Announces University of Miami as Clinical Site for ANGEL Trial of LipiCell(TM)
Regenerative Medicine Cardiology
 HSMN NewsFeed - 14 Feb 2012
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology
Regenerative Medicine Cardiology
 HSMN NewsFeed - 28 Mar 2011
Medtronic Announces FDA Approval of Protecta(TM) Implantable Defibrillators That Reduce Inappropriate Shocks
Devices Cardiology FDA
 HSMN NewsFeed - 18 Nov 2010
University Hospital of Nantes Presents 18-Year Experience with SynCardia’s Total Artificial Heart
Devices Cardiology
 HSMN NewsFeed - 2 Sep 2010
Cardiogenesis Comments on the STAR-Heart Study Presented at European Society of Cardiology (ESC) 2010 Congress
Regenerative Medicine Devices Cardiology
 HSMN NewsFeed - 17 Jun 2010
Medtronic Announces European Launch of Protecta Portfolio with SmartShock Technology Shown to Significantly Reduce Inappropriate Shocks
Devices Cardiology
 HSMN NewsFeed - 17 Jun 2010
St. Jude Medical Announces First Enrollment in Landmark Clinical Trial of Novel Heart Failure Management System
Devices Monitoring Cardiology
 HSMN NewsFeed - 15 Jan 2009
Cleveland Clinic to Present Results from Study Using Ivivi Technologies' tPEMF(tm) on Cardiac Ischemia At American College of Cardiology Annual Meeting
Devices Cardiology
 HSMN NewsFeed - 13 May 2008
St. Jude Medical Announces Start of Landmark DETERMINE ICD Study
Devices Cardiology
 HSMN NewsFeed - 29 Jun 2007
Ivivi Technologies Announces Completion of Patient Enrollment for its Cardiac Clinical Trial at The Cleveland Clinic Florida
Devices Cardiology
 HSMN NewsFeed - 22 May 2007
MicroMed Announces First Implant of the DeBakey VAD(R) X2 Design in the United Kingdom
Devices Cardiology
 HSMN NewsFeed - 17 May 2007
Celladon and Targeted Genetics Initiate Phase I Clinical Trial of MYDICAR(TM) in Patients With Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 26 Mar 2007
Largest Prospective Study of Microvolt T-Wave Alternans in Patients with Non-ischemic Cardiomyopathy Confirms the Predictive Value of MTWA
Devices Cardiology
 HSMN NewsFeed - 13 Sep 2006
Vasogen's Celacade(TM) Shown to Significantly Reduce Time in Hospital in Prime Heart Failure Target Population
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 8 May 2006
Largest US Study Confirms Predictive Ability of Microvolt T-Wave Alternans
Devices Cardiology
Return to NewsFeed  

 Additional items found! 17

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 17 additional stories matching:
ischemic cardiomyopathy
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!